Multidisciplinary Cancer Investigation
Sat, Oct 17, 2026
[Archive]
Multidisciplinary Cancer Investigation
Back to the articles list |
Back to browse issues page
Department of Biomedical Engineering, Apadana Institute of Higher Education, Shiraz, Iran , apadanaaivazi1399@gmail.com
Abstract: (6 Views)
The Importance of Study: Ovarian cancer remains a major global oncological burden due to its late-stage diagnosis and high mortality. Despite progress in surgery, chemotherapy, and targeted therapies, patient outcomes are often hindered by recurrence and chemoresistance. Early detection remains inadequate, emphasizing the need for innovative treatments.
Methods: Targeted nanotherapeutics offer a promising approach by enabling precise drug delivery through nanoscale carriers that enhance solubility, bioavailability, and tumor-specific accumulation while reducing systemic toxicity.
Results: Nanoscale drug carriers demonstrated enhanced bioavailability, with preferential tumor accumulation leading to improved therapeutic efficacy.
Conclusions: This review summarizes the current challenges in ovarian cancer management and highlights the potential of targeted nanodelivery systems to improve therapeutic efficacy and survival through controlled, cancer-specific drug-release mechanisms.
Methods: Targeted nanotherapeutics offer a promising approach by enabling precise drug delivery through nanoscale carriers that enhance solubility, bioavailability, and tumor-specific accumulation while reducing systemic toxicity.
Results: Nanoscale drug carriers demonstrated enhanced bioavailability, with preferential tumor accumulation leading to improved therapeutic efficacy.
Conclusions: This review summarizes the current challenges in ovarian cancer management and highlights the potential of targeted nanodelivery systems to improve therapeutic efficacy and survival through controlled, cancer-specific drug-release mechanisms.
Keywords: Ovarian Cancer, Nanotherapeutics, Targeted Drug Delivery, Smart Delivery Systems, Active Targeting
Select article type: Review Article |
Subject:
Immunotherapy and Targeted Therapies
Received: 2025/09/15 | Accepted: 2026/08/15
Received: 2025/09/15 | Accepted: 2026/08/15
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
